The MWCSD
Sleep Blog
Expert perspectives on sleep medicine, research breakthroughs, and practical advice — written by our board-certified physicians.
Oxygen at Night: Workup and Coverage
Nocturnal hypoxemia is common, consequential, and procedurally unforgiving when it comes to getting oxygen covered. Dr. Vishal Saini lays out a clean workup for sleep-related desaturation with and without comorbid sleep apnea, then walks through exactly how to meet Medicare and BCBSM requirements so the oxygen actually gets paid for.
Right Drug, Right Dose, Right Patient: Pharmacogenomics Tools Every Sleep Clinician Should Know in 2026
Why does one patient sleep soundly on a low dose while another is groggy until noon on the same prescription? Increasingly, the answer is in the genes that govern drug metabolism. Dr. Vishal Saini surveys the pharmacogenomics tools now available to sleep clinicians — the guidelines, databases, and gene-drug pairs that actually matter — with an honest take on where testing helps and where it's oversold.
Comprehensive Sleep Care Comes to Traverse City: Our New State-of-the-Art Sleep Lab Is Open
This September, Mid-West Center for Sleep Disorders opened a new three-bed, state-of-the-art sleep laboratory in Traverse City. After two years of clinic and home-testing service, we can now offer comprehensive sleep care — including full in-lab studies and pediatric sleep studies for children ages 3 and up — close to home. A note to our referring providers across northern Michigan.
The Mask Makes the Therapy: A 2026 Guide to Choosing the Right CPAP Mask — and Reading Your Leak Data
The machine gets the attention, but the mask is where CPAP succeeds or fails. Dr. Vishal Saini reviews how CPAP masks have changed in the last few years, which mask suits which patient, what the research says about mask choice, why fit and comfort determine whether therapy works — and the question he's asked most: when to worry about your leak number and when to ignore it.
"My Sleep Doctor Recommended a GLP-1 Drug for My Sleep Apnea — Now What?"
For the first time there's an FDA-approved medication for obstructive sleep apnea — a GLP-1-class drug. Dr. Vishal Saini explains how these drugs treat apnea, what the landmark SURMOUNT-OSA trial showed, who they're right for, the cautions every patient and clinician should know, and whether they change the disease or just hold it at bay.
Rewriting the Script: What the Latest Research Says About Treating Nightmare Disorder
Chronic nightmares aren't just bad dreams to wait out — they're a treatable condition, and the first-line treatment isn't a pill. Dr. Vishal Saini reviews the latest evidence: why imagery rehearsal therapy outperforms medication, what happened when prazosin faced its largest rigorous trial, and the striking new science of rewriting a nightmare during REM sleep.
Mild on Paper, Not in Your Body: Why REM-Related Sleep Apnea Shouldn't Be Ignored — Even When Your AHI Looks Low
Your sleep study says "mild" — an AHI of 6, maybe 9 — so you were told not to worry. But if nearly all of those events are packed into REM sleep, that reassuring average can hide a much more dangerous problem. Dr. Vishal Saini explains REM-related obstructive sleep apnea: why it's uniquely harmful, what the latest research links it to, why it slips past home tests, and why a low overall number is exactly when to look closer.
More Than Stronger Air: How VPAP-ASV Outsmarts Auto-CPAP — and Why That Difference Can Be Life-or-Death
If your CPAP is working but your "central" events aren't controlled — or a sleep physician has recommended an ASV machine instead of a standard CPAP — it helps to understand what makes adaptive servo-ventilation fundamentally different and far more sophisticated. Dr. Vishal Saini explains how VPAP-ASV actively stabilizes your breathing rather than just propping the airway open, who needs it, and the critical safety line that means it can never be a mail-order device.
The Invisible Gatekeeper: How Prior Authorization Delays Your Sleep Care — and What You Can Actually Do About It
If you've ever waited days or weeks for a sleep medication your doctor already prescribed, you've met prior authorization — a hurdle put up by your insurer and its pharmacy benefit manager, not by your clinic. Dr. Vishal Saini explains why sleep prescriptions get hit especially hard, why your care team can't simply override it, and the concrete steps that put some of the power back in your hands.
The Head at Rest: A Cross-Cultural History of the Pillow
How great civilizations solved the same nightly problem in radically different ways — and what their headrests, ceramic pillows, reclining gods, and painted couches reveal about status, the body, and the meaning of sleep. A cross-cultural history of the pillow across Egypt, Asia, India, and Greece.
Is There a Pill for Deep Sleep? A Sleep Physician's Review of the Drugs That Increase N3 — and Why Most of Them Aren't the Answer
After the habits, the schedule, the exercise, and CBT-I, some patients still ask the obvious question: isn't there a pill to give me more deep sleep? It's a fair question with an uncomfortable answer. Dr. Vishal Saini reviews the pharmacology of slow-wave sleep — the handful of drugs that genuinely increase N3, the far larger number that quietly reduce it, and why "more deep sleep from a bottle" is almost never the right treatment goal.
One Test Can't See the Whole Night: Why a Full Sleep Lab Beats an Online Home-Test-Only Program
Mail-order home sleep tests are convenient and useful for the right patient. But an online program built around a single home test is a screening funnel, not sleep care — it can only look for one disease, can't confirm its own misses, and has nowhere to send you when the answer is more complicated. Dr. Vishal Saini explains what a sleep clinic with its own fully equipped lab does differently, and why it matters for your diagnosis and your outcome.
Correlation Is Not a Diagnosis: Reading PAT and Cardiopulmonary-Coupling Sleep Tests More Skeptically
Peripheral arterial tonometry and cardiopulmonary coupling have made home sleep testing cheap and everywhere. They're useful tools — but they measure your breathing indirectly, through your autonomic nervous system, and the confident numbers they produce invite conclusions the technology can't support. Dr. Vishal Saini explains where these devices earn their keep, where the data gets over-read, and how to confirm findings against the gold standard.
Chasing Deep Sleep: What Actually Builds More N3 — and What's Just Noise
Everyone wants more "deep sleep," and the internet is happy to sell it to you. But only a handful of things reliably increase N3 slow-wave sleep — and for people with insomnia, the highest-yield move isn't a supplement or a gadget at all. Dr. Vishal Saini separates the evidence-based levers from the wishful thinking, and gives insomnia patients a realistic plan.
Does the Gummy on Your Nightstand Actually Help You Sleep? What the Cannabinoid Evidence Really Says
CBD, THC, and CBN sleep products are a multibillion-dollar category built on a thin evidence base — and on a few biological facts that should give every insomnia patient pause. Dr. Vishal Saini walks through what cannabinoids actually do to your sleep, what the latest trials show, what to realistically expect, and the cautions that rarely make it onto the label.
Putting a Brain Wave in the Bedroom: The Promise and Pitfalls of Adding EEG to Home Sleep Tests
The next wave of home sleep apnea testing wants to read your brain, not just your breathing. That's a genuine upgrade — and a genuine source of new ways to be misled. Dr. Vishal Saini explains what EEG adds to a home sleep test, where the evidence is strong, where it's thin, and the questions clinicians and patients should ask before trusting the number on the screen.
Sleep Apnea and Testosterone: Why Treating the Wrong Problem First Can Set You Back
Many men with untreated sleep apnea are prescribed testosterone replacement therapy — but the order matters. Untreated OSA disrupts testosterone at its source, and TRT can worsen sleep apnea. Dr. Vishal Saini explains the science, the sequencing, and what men in Lansing, Traverse City, and Eaton Rapids should know.
When the Treatment Becomes the Problem: What the Latest Research Says About RLS Augmentation
Restless legs syndrome can worsen paradoxically over time on the very medications meant to treat it — a phenomenon called augmentation. Dr. Saini explains the dose escalation trap, why the entire first-line treatment paradigm has been reversed by the 2025 AASM guidelines, and what the current evidence says about getting patients off dopamine agonists safely.
She Felt Better on CPAP. Then She Didn't. Here's Why That's Clinically Important.
Many patients with obstructive sleep apnea feel significantly better on CPAP for the first few months — then the hypersomnia returns, even though the device data looks fine. This isn't a compliance failure. It's a diagnostic signal. Dr. Saini explains the CPAP honeymoon effect, why OSA can mask underlying hypersomnia disorders like narcolepsy type 2 and idiopathic hypersomnia, and what the evidence-based workup looks like when CPAP stops working.
Your Dentist Calls It Grinding. Your Brain Calls It Something Else.
Most people assume sleep bruxism is caused by stress — but the research tells a different story. Sleep bruxism is classified as a sleep movement disorder, driven by brain arousal circuitry, dopamine pathways, and genetics. Dr. Vishal Saini explains what's actually happening in the brain when you grind at night.
Before Starting Xywav or Lumryz, Ask Yourself: How Did Your Body Respond to These Other Medications?
Your prior response to baclofen, gabapentin, or benzodiazepines may reveal meaningful signals about whether Xywav or Lumryz will work for you — but the hierarchy of which drugs matter most as predictors is not what most clinicians assume. Dr. Vishal Saini explains the pharmacological reasoning.
"Benadryl Knocks Me Out Cold" — Does That Mean Pitolisant Will Work Well for You? The Science Says: Not So Fast.
If antihistamines knock you out, does that mean pitolisant will supercharge your wakefulness? The pharmacology says no — and understanding why reveals something important about how narcolepsy and IH affect the histamine system. Dr. Vishal Saini explains the science.
What Your Deep Sleep Percentage Actually Tells Us — And Why It May Predict Whether Oxybate Works for You
Your N3 slow-wave sleep percentage on a sleep study may be one of the most important biomarkers for predicting oxybate response — but the story is fundamentally different for Narcolepsy vs. Idiopathic Hypersomnia. Dr. Vishal Saini explains the emerging science and what it means for your treatment.
MWCSD Now Enrolling: Brilliance Phase III Clinical Trial for Narcolepsy
Mid-West Center for Sleep Disorders is proud to announce the launch of the Brilliance Phase III clinical trial for narcolepsy, sponsored by Alkermes. We are now actively enrolling qualified patients across our Michigan locations.
Introducing The Hidden Sleep Disorders Show
Dr. Vishal Saini launches a new podcast dedicated to uncovering the medical conditions hiding behind unexplained fatigue and poor sleep.
Newsletter
Never miss a new article
Get a quick email whenever we publish new content — no spam, just sleep science.
Ready to Sleep Better?
Reading is a start — but lasting change comes from expert care. Book a consultation with our board-certified sleep physicians.
Book an Appointment